Jed Wiltzius

Title: The Innovative Contributions of Jed Wiltzius

Introduction

Jed Wiltzius is a prominent inventor based in Woodland Hills, California. He has made significant contributions to the field of biotechnology, particularly in the development of antigen binding molecules and chimeric receptors. With a total of 12 patents to his name, Wiltzius has established himself as a key figure in the industry.

Latest Patents

Among his latest patents, one notable invention is the "Antigen binding molecules specific for an anti-CD19 scFV." This patent provides isolated antigen binding molecules that specifically bind to an anti-CD19 scFv, which can be utilized in various methods. Another significant patent is for "Chimeric receptors to DLL3 and methods of use thereof." This invention discloses antigen binding molecules, chimeric receptors, and engineered immune cells to DLL3, along with vectors, compositions, and methods for treatment and detection using these innovative molecules.

Career Highlights

Jed Wiltzius has worked with leading companies in the biotechnology sector, including Kite Pharma, Inc. and Amgen Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field.

Collaborations

Throughout his career, Wiltzius has collaborated with notable professionals, including Stuart A. Sievers and Ruben Alvarez Rodriguez. These partnerships have further enhanced his work and innovation in biotechnology.

Conclusion

Jed Wiltzius is a distinguished inventor whose work in antigen binding molecules and chimeric receptors has made a significant impact in biotechnology. His contributions continue to advance the field and inspire future innovations.